Organization | InVasc Therapeutics, Inc.

InVasc Therapeutics, Inc. Report issue

For profit Phase 2 Phase 4

Founded: Tucker GA United States (2006)

Status: Defunct (2011)

Organization Overview

First Clinical Trial

2008

NCT00795262

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2011

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (4)

amlodipine (norvasc) (1 trial)

hydrochlorothiazide (esidrix) (2 trials)

losartan (cozaar) (2 trials)

olmesartan (benicar) (1 trial)

Drugs in Phase 2 Trials (1)

inv-144 (1 trial)

Drugs in Other Trials (3)

alpha-lipoic acid (1 trial)

nebivolol (bystolic) (1 trial)

quinapril (accupril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Hypertension (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 8